Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.

The article discusses the effectiveness of the oral metronomic chemotherapy (MC), DEVEC (Deltacortene, etoposide, vinorelbine, cyclophosphamide), as treatment for aggressive lymphomas in elderly patients. Also cited are the study conducted on patients with aggressive B- and T-cell lymphomas, as well as the results like estimated median overall survival (OS), progression-free survival (PFS), and the estimated direct cost of drugs.